Fig. 4

Forest plots representing the prevalence of relapse, flare, or exacerbation based on the type of vaccine in all patients with autoimmune and immune-mediated diseases (AI-IMD) (p-value = 0.0086) (A), patients with rheumatic and musculoskeletal diseases (p-value = 0.0882) (B), and neurologic (p-value = 0.0108) (C) autoimmune diseases following the COVID-19 vaccination